Merrimack Announces Major Corporate Restructuring
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
BTIG Affirms Merrimack Pharma (MACK) at 'Neutral' Amid Restructuring Plans
October 4, 2016 10:30 AM EDTBTIG affirms Merrimack Pharma (Nasdaq: MACK) with a Neutral rating following news that the company is undertaking a corporate restructuring.
BTIG commented late Monday, MACK announced a major corporate restructuring that cuts headcount by 22% and reduces $200M+ in expected expenses over the... More
